CSIMarket
 

Rani Therapeutics Holdings Inc   (RANI)
Other Ticker:  
 

Rani Therapeutics Holdings Inc 's

Competitiveness


 

RANI Sales vs. its Competitors Q3 2023







Revenue Growth Comparisons




Net Income Comparison




<<  RANI Stock Performance Comparisons



*Market share is calculated based on total revenue.

  News about Rani Therapeutics Holdings Inc Contracts

Revolutionizing Drug Delivery: Rani Therapeutics' Preclinical Data Shows Promise in Transenteric Delivery of GLP-1 Incretin Triagonist


In a significant advancement in oral drug delivery, Rani Therapeutics, a pioneer in oral biologics, has revealed compelling preclinical pharmacodynamic data on the transenteric delivery of GLP-1 Incretin Triagonist. This disclosure underscores the immense potential of Rani's cutting-edge drug delivery technology to revolutionize the treatment of metabolic diseases, dramatically transforming the prospects for the company.
Transenteric delivery pertains to a novel drug administration method wherein drugs are delivered transversely through the intestinal wall, bypassing the traditional oral route. In the recent preclinical study, the transenteric delivery of the incretin triagonist of GLP-1, GIP, and g...





Who are Rani Therapeutics Holdings Inc 's Competitors?





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com